Intellectual Property

Biocon R&D has consistently created intellectual wealth through an incisive intellectual property strategy that recognises the innovative potential of our products and processes.

We have filed over 1,200 patent applications and hold around 984 patents and 448 trademark registrations globally. This number is only expected to increase as our exciting novel molecules pipeline advances from the bench to the bedside in the coming years. This team has won the ‘Best In-house IP Team of the Year’ Award at the Global IP conclave held in 2015 and the Pharmexcil Gold Patent Award 2014-15 in the Biotech category for filing the highest number of patents.